Articles
| Open Access |
DOI: COMPARATIVE ANALYSIS OF THE FREQUENCY OF RS1801133 POLYMORPHISM OF THE MTHFR GENE IN THE GROUP OF PATIENTS WITH POSTCOVID COMPLICATIONS OF MAXILLOFACIAL AREA
Sh.A. Boymuradov , Tashkent Medical Academy, Uzbekistan Y.Kh. Kurbonov , Tashkent Medical Academy, Uzbekistan J.A.Djuraev , Tashkent Medical Academy, UzbekistanAbstract
In the article of genetic studies of patients with post-covid maxillofacial complications. The condition after COVID-19 is considered a life-threatening disease, ranging from mild symptoms to serious complications. Candidiasis is the most common type of superficial purulent infection. The Candida species is a frequent inhabitant of the oral mucosa, but its growth is inhibited by other organisms in the body, which prevents any pathological change in the mucous membrane of this fungus. Candida albicans is the most common yeast, followed by Candida glabrata, Candida krusei, Candida tropicalis and Candida stellatoidea. According to this systematic review, 57 cases of oral candidiasis and one case of retinitis candidiasis were reported in patients undergoing treatment for COVID-19. Single-cell RNA-seq analysis of angiotensin-converting enzyme II (ACE2) expression and serologic examination of samples indicates that ACE2 may be the cellular receptor for SARS-CoV-2, suggesting that ACE2-expressing cells are likely to be the main target cell type that vulnerable to SARS-CoV-2 infection. As a rule, there is a high expression of ACE2 r on the epithelial cells of the oral mucosa, enrichment is enriched in epithelial cells of the tongue. There were few reports prior to this study.
Keywords
Post-covid maxillofacial complications, COVID-19, oral mucosa, Candida
References
Van Der Made C. I. et al. Presence of genetic variants among young men with severe COVID-19 //Jama. – 2020. – Т. 324. – №. 7. – С. 663-673.
Ross J., Sun L. Ninety days in: a comprehensive review of the ongoing COVID-19 outbreak //Health Sci. J. – 2020. – Т. 14. – С. 706.
Kuehn B. M. Massive study compilation illuminates regulatory role of non–gene-encoding dna //JAMA. – 2012. – Т. 308. – №. 14. – С. 1419-1420.
Patel Z. M. et al. Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic //Neurosurgery. – 2020. – Т. 87. – №. 1. – С. E66-E67.
Ortiz-Prado E. et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review //Diagnostic microbiology and infectious disease. – 2020. – Т. 98. – №. 1. – С. 115094.
Hannum M. E. et al. The genetics of eating behaviors: research in the age of COVID-19 //bioRxiv. – 2021.
Lutz K. L. et al. Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy //Neurology. – 2013. – Т. 81. – №. 16. – С. 1374-1377.
Hutchinson N. T., Steelman A., Woods J. A. Behavioral strategies to prevent and mitigate COVID-19 infection //Sports Medicine and Health Science. – 2020.
AlTakarli N. S. China’s response to the COVID-19 outbreak: A model for epidemic preparedness and management //Dubai Medical Journal. – 2020. – Т. 3. – №. 2. – С. 44-49.
Sinha K. et al. Covid-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy //Journal of Pharmaceutical Analysis. – 2021.
Guidon A. C., Amato A. A. COVID-19 and neuromuscular disorders //Neurology. – 2020. – Т. 94. – №. 22. – С. 959-969.
Shorten C., Khoshgoftaar T. M., Furht B. Deep Learning applications for COVID-19 //Journal of big Data. – 2021. – Т. 8. – №. 1. – С. 1-54.
Adhikari S. et al. Nanomaterials for diagnostic, treatment and prevention of COVID-19 //Applied Science and Technology Annals. – 2020. – Т. 1. – №. 1. – С. 155-164.
Rubin R. Testing an old therapy against a new disease: convalescent plasma for COVID-19 //Jama. – 2020. – Т. 323. – №. 21. – С. 2114-2117.
Kakodkar P., Kaka N., Baig M. N. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19) //Cureus. – 2020. – Т. 12. – №. 4.
Stawicki S. P. et al. The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper //Journal of global infectious diseases. – 2020. – Т. 12. – №. 2. – С. 47.
Syamal M. Literature‐guided recommendations for otolaryngologists during the COVID‐19 pandemic: A contemporary review //Laryngoscope Investigative Otolaryngology. – 2020. – Т. 5. – №. 3. – С. 432-437.
Article Statistics
Copyright License
Copyright (c) 2022 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.